Former Chief Commercial Officer · Zymeworks Inc. (ZYME)

James Priour

FY2021 is the first fiscal year CompBrief holds for James Priour as a named executive officer of Zymeworks; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,541,343

Salary $400,000Stock awards $217,625

6th of 6 named executive officers at Zymeworks by FY2021 total.

6 named officers on file for Zymeworks, FY2021

James Priour’s pay file — $29

  • 1 fiscal year of pay, line by line
  • ZYME’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Zymeworks’s whole pay program stands against its peers

  • Zymeworks’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ZYME→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed November 25, 2022 (DEF 14A).

Free

Get James Priour’s full pay file as a PDF — free

More than this page: up to 10 years of James’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

James Priour compensation by year

Zymeworks Summary Compensation Table · the one fiscal year held
In US dollars, as Zymeworks reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$400,000
Bonus$0
Stock awards$217,625
Option awards$906,280
Non-equity incentive$0
Pension and deferred compensation$0
All other$17,438
Total$1,541,343

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zymeworks Inc. DEF 14A filed November 25, 2022, accession 0001193125-22-292281, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Zymeworks Inc. filed document, accession 0001193125-22-292281. Every figure is read from that document and cited to the page and table it appears in. Filed November 25, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU6,250$217,625—
RSU4,534$170,705—
Option22,950—$37.65
Option37,500—$34.82

Per the Outstanding Equity Awards at Fiscal Year-End table in Zymeworks Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Zymeworks’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Ali TehraniFormer President & CEO$5,110,637
Neil JosephsonChief Medical Officer$3,547,690
Anthony PolverinoFormer Executive VP, Early Development & Chief Scientific Officer$1,917,908
Neil KlompasFormer President & COO$1,900,478
Diana HausmanFormer Chief Medical Officer$1,646,089
James Priour · this pageFormer Chief Commercial Officer$1,541,343

The full Zymeworks compensation record

free company brief

This page is one person within Zymeworks's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Zymeworks proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zymeworks's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

James Priour's compensation dossier · One-time report. No refunds.